1Suppliers
1Customers
2Debt Items
0Related Chains

OS Therapies Incorporated Suppliers

TickerNameConfidenceEvidence
AYALA-PHARMACEUTICALS-INC AYALA-PHARMACEUTICALS-INC 90% In connection with the acquisition, the Company assumed certain specified liabilities and paid an aggregate purchase price of $ 8,000,000

OS Therapies Incorporated Customers

TickerNameConfidenceEvidence
AYALA-PHARMACEUTICALS-INC AYALA-PHARMACEUTICALS-INC 85% NOTE 2 — SIGNIFICANT ACCOUNTING POLICIES (cont.) Fixed Asset Policy A capital asset is defined as a unit of property that has an economic useful life that extends beyond 12 months. Any items costing …

OS Therapies Incorporated Debt Obligations

InstrumentDescriptionConfidenceEvidence
OSTX-DEBT-11611 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.
OSTX-DEBT-11610 Warrants outstanding: 444041 90% xbrl warrant detail from xbrl 2025-12-31.

OS Therapies Incorporated Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for OS Therapies Incorporated.

OS Therapies Incorporated Ownership

HolderNameConfidenceEvidence
OSTX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 29 tracked holders.

OS Therapies Incorporated Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.